Small molecule ectonucleotide pyrophosphatase/phosphodiesterase 1 inhibitors in cancer immunotherapy for harnessing innate immunity

被引：5
|
作者：
Choi, Junwon [1 ]
机构：
[1] Ajou Univ, Dept Mol Sci & Technol, Suwon, Gyeonggi, South Korea
来源：
BULLETIN OF THE KOREAN CHEMICAL SOCIETY | 2023年 / 44卷 / 02期
基金：
新加坡国家研究基金会;
关键词：
cancer immunotherapy; cGAMP; ENPP1; inhibitor; innate immunity; STING; CYCLIC GMP-AMP; NUCLEOTIDE PYROPHOSPHATASE; EXTRACELLULAR CGAMP; POTENT INHIBITORS; BYSTANDER CELLS; HUMAN NPP1; DERIVATIVES; HYDROLYSIS; 2ND-MESSENGER; ENPP1;
D O I：
10.1002/bkcs.12646
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) was recently identified as a major hydrolase of an endogenous stimulator of interferon genes (STING) agonist, 2 ',3 '-cyclic guanosine monophosphate-adenosine monophosphate (cGAMP). ENPP1 is a promising therapeutic target in cancer immunotherapy, in which the inhibition of ENPP1 enhances anticancer immunity via STING-mediated innate immune activation. This review highlights the role of ENPP1 in innate immunity and the recent discovery of small molecule ENPP1 inhibitors as immunomodulators in cancer immunotherapy.
引用
收藏
页码：88 / 99
页数：12
相关论文
共 50 条
  • [21] Synthesis of triazole Schiff bases: Novel inhibitors of nucleotide pyrophosphatase/phosphodiesterase-1
    Khan, Khalid Mohammed
    Siddiqui, Salman
    Saleem, Muhammad
    Taha, Muhammad
    Saad, Syed Muhammad
    Perveen, Shahnaz
    Choudhary, M. Iqbal
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (22) : 6509 - 6514
  • [22] Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017-present)
    Nocentini, Alessio
    Capasso, Clemente
    Supuran, Claudiu T.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2021, 31 (10) : 867 - 876
  • [23] Small-molecule agents for cancer immunotherapy
    Wang, Fang
    Fu, Kai
    Wang, Yujue
    Pan, Can
    Wang, Xueping
    Liu, Zeyu
    Yang, Chuan
    Zheng, Ying
    Li, Xiaopeng
    Lu, Yu
    To, Kenneth Kin Wah
    Xia, Chenglai
    Zhang, Jianye
    Shi, Zhi
    Hu, Zeping
    Huang, Min
    Fu, Liwu
    ACTA PHARMACEUTICA SINICA B, 2024, 14 (03) : 905 - 952
  • [24] Nucleic acid and oligonucleotide delivery for activating innate immunity in cancer immunotherapy
    Meng, Fanfei
    Wang, Jianping
    Yeo, Yoon
    JOURNAL OF CONTROLLED RELEASE, 2022, 345 : 586 - 600
  • [25] Biological roles of A-to-I editing: implications in innate immunity, cell death, and cancer immunotherapy
    Jing Yuan
    Li Xu
    Hai-Juan Bao
    Jie-lin Wang
    Yang Zhao
    Shuo Chen
    Journal of Experimental & Clinical Cancer Research, 42
  • [26] Biological roles of A-to-I editing: implications in innate immunity, cell death, and cancer immunotherapy
    Yuan, Jing
    Xu, Li
    Bao, Hai-Juan
    Wang, Jie-lin
    Zhao, Yang
    Chen, Shuo
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [27] Recent advances in small molecule based cancer immunotherapy
    Cheng, Binbin
    Yuan, Wei-En
    Su, Jing
    Liu, Yao
    Chen, Jianjun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 157 : 582 - 598
  • [28] Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model
    Caisova, Veronika
    Vieru, Andra
    Kumzakova, Zuzana
    Glaserova, Simona
    Husnikova, Hana
    Vacova, Nikol
    Krejcova, Gabriela
    Padoukova, Lucie
    Jochmanova, Ivana
    Wolf, Katherine I.
    Chmelar, Jindrich
    Kopecky, Jan
    Zenka, Jan
    BMC CANCER, 2016, 16
  • [29] Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model
    Veronika Caisová
    Andra Vieru
    Zuzana Kumžáková
    Simona Glaserová
    Hana Husníková
    Nikol Vácová
    Gabriela Krejčová
    Lucie Paďouková
    Ivana Jochmanová
    Katherine I. Wolf
    Jindřich Chmelař
    Jan Kopecký
    Jan Ženka
    BMC Cancer, 16
  • [30] Coley's immunotherapy revived: Innate immunity as a link in priming cancer cells for an attack by adaptive immunity
    Uher, Ondrej
    Caisova, Veronika
    Hansen, Per
    Kopecky, Jan
    Chmelar, Jindrich
    Zhuang, Zhengping
    Zenka, Jan
    Pacak, Karel
    SEMINARS IN ONCOLOGY, 2019, 46 (4-5) : 385 - 392
12345